Overall U.S. Costs of Cancer to Spike to $158 Billion by 2020
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 04/30/13 -- TriMark Publications (), a global leader in biotechnology, healthcare and life sciences publishing, announces the release of its report. is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The American Cancer Society estimates that approximately 1,660,290 new cancer cases are expected to be diagnosed in 2013. Overall costs of the disease will reach at least $158 billion in the U.S. by 2020.
The goal of this TriMark Publications report is to review the market for tumor marker testing equipment and supplies using screening reagents and instruments for analysis of individual components in blood, serum or plasma. It defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence the size and the growth of the market segments. Also examined are the subsections of each market segment, including: the physician office labs, hospital labs and commercial laboratories.
The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the market in the U.S. Each company is discussed in depth with a section on its history, product line, business and marketing analysis, and a subjective commentary on the company's market position. The following areas are addressed in this analysis:
DNA Markers
Serum Proteins
Enzymes
Occult Blood
Histology and In Situ Hybridization (ISH)
Cervical Cytology
Immunohistochemistry
In Vivo Detection Cancer Products
Radionuclides and X-Ray Detection Products
Human Papillomavirus (HPV) Testing
Bladder Cancer Testing
Tumor Assays for Adjuvant Chemotherapy
Organ Specific Tumor Markers
Colon Cancer
Prostate Cancer
Pancreatic Cancer
Breast Cancer
Ovarian Cancer
Cervical Cancer
Lung Cancer
Testicular Cancer
Bladder Cancer
Hepatic Cancer
Stomach Cancer
Malignant Melanoma
Acute Myeloid Leukemia (AML)
Acute Lymphoblastoid Leukemia (ALL)
Lymphoma
For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMark Publications, LLC
212.265.9877
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.04.2013 - 17:45 Uhr
Sprache: Deutsch
News-ID 254655
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Venture Capital
Diese Pressemitteilung wurde bisher 234 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Overall U.S. Costs of Cancer to Spike to $158 Billion by 2020"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
